Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance-Reference-Cited by-同舟云学术

Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance

Published:2010 Issue: Volume: Page:NA-NA
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Fuchs Dieter,Rodriguez Alejandro,Eriksson Sara,Christofferson Rolf,Sundberg Christian,Azarbayjani Faranak

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference73 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma;Bordow;Cancer Res,1994

3. Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma;Norris;New Engl J Med,1996

4. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies;Mimeault;Clin Pharmacol Ther,2008

5. Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982-1992;Cotterill;Eur J Cancer,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors;Trends in Cancer;2021-08

2. OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis;Leukemia;2020-01-02

3. Tumor endothelial cells as a potential target of metronomic chemotherapy;Archives of Pharmacal Research;2019-01

4. Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data;Cancer Letters;2018-09

5. Tumor Dormancy, Angiogenesis and Metronomic Chemotherapy;Cancer Drug Discovery and Development;2017